One factor that sparked interest in using NSAIDs is the imbalance of the RAS in favor of the proinflammatory peptide Ang II in COVID-19 patients, and these anti-inflammatory agents could restore it, as was shown in animal and human studies [17,70,71]. The gene discussed is AGT; the disease is COVID-19.